share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick

Novavax | 4: Statement of changes in beneficial ownership of securities

诺瓦瓦克斯医药 | 4：持股变动声明
SEC announcement ·  03/11 21:43
Moomoo AI 已提取核心信息
James Patrick Kelly, EVP, CFO, and Treasurer of Novavax Inc, completed a stock transaction involving the company's common stock on March 7, 2024. Kelly executed a sale of 5,905 shares at a price of $5.61 per share, resulting in a total transaction value of $33,127.05. Following this transaction, Kelly holds a total of 10,903 shares of Novavax common stock. The sale was part of a transaction that also included the exercise or conversion of derivative securities, which resulted in the acquisition of 12,224 shares on the same date.
James Patrick Kelly, EVP, CFO, and Treasurer of Novavax Inc, completed a stock transaction involving the company's common stock on March 7, 2024. Kelly executed a sale of 5,905 shares at a price of $5.61 per share, resulting in a total transaction value of $33,127.05. Following this transaction, Kelly holds a total of 10,903 shares of Novavax common stock. The sale was part of a transaction that also included the exercise or conversion of derivative securities, which resulted in the acquisition of 12,224 shares on the same date.
Novavax Inc执行副总裁、首席财务官兼财务主管詹姆斯·帕特里克·凯利于2024年3月7日完成了一项涉及公司普通股的股票交易。凯利以每股5.61美元的价格出售了5,905股股票，总交易价值为33,127.05美元。在这笔交易之后，凯利共持有10,903股Novavax普通股。此次出售是交易的一部分，该交易还包括行使或转换衍生证券，该交易导致同日收购了12,224股股票。
Novavax Inc执行副总裁、首席财务官兼财务主管詹姆斯·帕特里克·凯利于2024年3月7日完成了一项涉及公司普通股的股票交易。凯利以每股5.61美元的价格出售了5,905股股票，总交易价值为33,127.05美元。在这笔交易之后，凯利共持有10,903股Novavax普通股。此次出售是交易的一部分，该交易还包括行使或转换衍生证券，该交易导致同日收购了12,224股股票。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息